Service expected to help companies discover partners in funding.
Pharma Targeting, a pharmaceutical market intelligence and data company, has announced the launch of ‘Partner Identifier’, an initiative designed to help pharma and biotech companies find the partners they need to get funded, noticed, and faster to market. According to the organization, the technology uses data-driven intelligence to help customers identify and engage with the right partner for licensing, in-licensing, funding, distribution, and other business needs.
“The Partner Identifier was born out of a client need, adjusted, and implemented to help them to identify and engage with the right partner, at the right time, with an aligning strategy and the necessary funds in place,” says Anil Kumar, founder, Pharma Targeting. “We do the challenging work of finding and contacting our clients’ potential partners, so that all they have to do is make connections and build relationships. The ultimate goal is helping our clients to achieve meaningful collaboration and partnership, and get their products to market quicker.”
Reference:
Pharma Targeting Launch ‘Partner Identifier’ to Intelligently Connect the Dots between Data and Business Opportunity for Pharma Clients. (2023, July 6).
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.